Immunosuppressant Regimen

DRUG2 trials

Sponsors

Vertex Pharmaceuticals Incorporated, Singapore General Hospital

Conditions

Hepatitis CInterstitial Lung DiseaseMyositis

Phase 2

An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients

TerminatedNCT01467505

Vertex Pharmaceuticals IncorporatedHepatitis C

Start: 2012-02-29End: 2014-04-30Updated: 2015-06-18

Unknown Phase

Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease

RecruitingNCT07775235

Singapore General HospitalInterstitial Lung Disease, Myositis

Start: 2024-12-26End: 2029-07-01Target: 80Updated: 2026-08-20